The effect of T cell depletion with Campath-1M on immune reconstitution after chemotherapy and allogeneic bone marrow transplant as treatment for leukaemia

Bone Marrow Transplantation

Volumn 21, Issue 7, 1998, Pages 679-686

  Lowdell, M W ^a   Craston, R ^a   Ray, N ^a   Koh, M ^a   Galatowicz, G ^a   Prentice, H G ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Allogeneic; Campath; Immune reconstitution; NK cells; T cells

Indexed keywords

ALEMTUZUMAB; ANTINEOPLASTIC AGENT; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN;

ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOGRAFT; ARTICLE; CANCER CHEMOTHERAPY; CELL MATURATION; CELL SELECTION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONDITIONING; DONOR; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE SYSTEM; IMMUNITY; INFUSION; LEUKEMIA; LEUKOCYTE; MALE; MEDICAL DECISION MAKING; NATURAL KILLER CELL; PRIORITY JOURNAL; PROPHYLAXIS; RELAPSE; REMISSION; RISK; STEM CELL TRANSPLANTATION; T LYMPHOCYTE;

EID: 0031945659     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701153     Document Type: Article

References (23)

1. Dicke KA, Van Hooft J, van Bekkum DW. The selective elimination of immunologically competent cells from bone marrow and lymphatic cell mixtures. Transplantation 1968; 6: 562-570.
2. van-Bekkum DW, Balner H, Dicke KA et al. The effect of pretreatment of allogeneic bone marrow graft recipients with anti-lymphocyte serum on the acute graft-versus-host reaction in monkeys. Transplantation 1972; 13: 400-407.
3. Reisner Y, Kapoor N, Kirkpatrick D et al. Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet 1981; ii: 327-331.
4. Prentice HG, Janossy G, Blacklock HA et al. Use of anti T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone marrow transplantation for acute leukaemia. Lancet 1982; i: 700-703.
5. Prentice HG, Blacklock HA, Janossy G et al. Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients. Lancet 1984; i: 472-476.
6. Waldmann G, Or R, Hale G et al. Elimination of graft versus host disease by in vitro depletion of alloreactive lymphocytes using a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1M). Lancet 1984; ii: 483-486.
7. Lowdell MW, Craston R, Prentice HG. Understanding the graft-versus-leukaemia reaction: progress towards the immunotherapy of leukaemia. Hematology 1997; 2: 193-201.
8. Hale G, Xia M-Q, Tighe HP et al. The CAMPATH-1 antigen (CDw52). Tissue Antigens 1990; 35: 118-127.
9. Wimperis JZ, Brenner MK, Drexler HG et al. Rapid recovery of helper activity following T cell depleted allogeneic marrow transplant. Clin Exp Immunol 1987; 69: 601-610.
10. Kelsey SM, Lowdell MW, Newland AC. IgG subclass levels and immune reconstitution after T cell-depleted allogeneic bone marrow transplantation. Clin Exp Immunol 1990; 80: 409-412.
11. Roux E, Helg C, Dumont-Giradr F et al. Analysis of T-cell repopulation after allogeneic bone marrow transplantation: significant differences between recipients of T-cell depleted and unmanipulated grafts. Blood 1986; 87: 3984-3992.
12. Kawachi Y, Watanabe H, Moroda T et al. Self-reactive T cell clones in a restricted population of interleukin-2 receptor beta+ cells expressing intermediate levels of the T cell receptor in the liver and other immune organs. Eur J Immunol 1995; 25: 2272-2278.
13. Snedecor GW. Statistical Methods Applied to Experiments in Agriculture and Biology. Iowa State Press: USA, 1956, pp 85-101 and 160-193.
14. Janossy G, Prentice HG, Grob J-P et al. T lymphocyte regeneration after transplantation of T cell depleted allogeneic bone marrow. Clin Exp Immunol 1986; 63: 577-586.
15. Foot ABM, Potter MN, Donaldson C et al. Immune reconstitution after BMT in children. Bone Marrow Transplant 1993; 11: 7-13.
16. Rooney CM, Wimperis JZ, Brenner MK et al. Natural killer cell activity following T-cell depleted allogeneic bone marrow transplantation. Br J Haematol 1986; 62: 413-120.
17. Wimperis JZ, Brenner MK, Prentice HG et al. B cell development and regulation after T cell-depleted marrow transplantation. J Immunol 1987; 138: 2445-2450.
18. Keever CA, Small TN, Flomenberg N et al. Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood 1988; 73: 1340-1350.
19. Akbar AN, Terry L, Timms A et al. Loss of CD45R antigen and gain of UCHL1 reactivity is a feature of primed T cells. J Immunol 1988; 140: 2171-2178.
20. Witherspoon RP, Kopecky K, Storb R et al. Immunological recovery in 48 patients following syngeneic marrow transplant for hematological malignancy. Transplantation 1982; 33: 143-149.
21. Singer CR, Tansey PJ, Burnett AK. T lymphocyte reconstitution following autologous bone marrow transplantation. Clin Exp Immunol 1983; 51: 455-460.
22. Reittie JE, Gottlieb D, Heslop H et al. Endogenously generated activated killer cells circulate after autologous and allogeneic marrow transplantation but not after chemotherapy. Blood 1989; 73: 1351-1358.
23. Lowdell MW, Ray N, Craston R et al. The in vitro detection of anti-leukaemia-specific cytotoxicity after autologous bone marrow transplantation for acute leukaemia. Bone Marrow Transplant 1997; 19: 891-897.